Beyond the increasing complexity of the immunomodulatory HLA-G molecule

被引:277
作者
Carosella, Edgardo D. [1 ]
Favier, Benoit [1 ]
Rouas-Freiss, Nathalie [1 ]
Moreau, Philippe [1 ]
LeMaoult, Joel [1 ]
机构
[1] Hop St Louis, Serv Rech Hematoimmunol, I2BM, CEA, F-75475 Paris, France
关键词
D O I
10.1182/blood-2007-12-127662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human leukocyte antigen G (HLA-G) is a nonclassic major histocompatibility complex (MHC) class I molecule that functions as an immunomodulatory molecule capable of protecting fetal tissues from the maternal immune system. The relevance of HLA-G in other contexts was investigated soon afterward. Numerous studies have sought (and some have shown) the relevance of HLA-G in pathologic conditions, such as transplantation, autoimmunity, and cancer and hematologic malignancies. One of the main goals of the current research on HLA-G is now to use it in the clinic, either for diagnosis or as a therapeutic tool/target. For this, precise knowledge on the nature and functions of HLA-G is critical. We highlight here what we consider are recent key basic findings on the immunomodulatory function of HLA-G. These strengthen the case for considering HLA-G as clinically relevant.
引用
收藏
页码:4862 / 4870
页数:9
相关论文
共 94 条
[1]   A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1 [J].
Apps, Richard ;
Gardner, Lucy ;
Sharkey, Andrew M. ;
Holmes, Nick ;
Moffett, Ashley .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (07) :1924-1937
[2]   HLA-G and NK receptor are expressed in psoriatic skin - A possible pathway for regulating infiltrating T cells? [J].
Aractingi, S ;
Briand, N ;
Le Danff, C ;
Viguier, M ;
Bachelez, H ;
Michel, L ;
Dubertret, L ;
Carosella, ED .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :71-77
[3]   Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes [J].
Bahri, R ;
Hirsch, F ;
Josse, A ;
Rouas-Freiss, N ;
Bidere, N ;
Vasquez, A ;
Carosella, ED ;
Charpentier, B ;
Durrbach, A .
JOURNAL OF IMMUNOLOGY, 2006, 176 (03) :1331-1339
[4]   HLA-G suppresses proliferation of CD4+ T-lymphocytes [J].
Bainbridge, DRJ ;
Ellis, SA ;
Sargent, IL .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 48 (01) :17-26
[5]   Disulfide bond-mediated dimerization of HLA-G on the cell surface [J].
Boyson, JE ;
Erskine, R ;
Whitman, MC ;
Chiu, M ;
Lau, JM ;
Koopman, LA ;
Valter, MM ;
Angelisova, P ;
Horejsi, V ;
Strominger, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) :16180-16185
[6]  
Bukur J, 2003, CANCER RES, V63, P4107
[7]   HLA-G revisited [J].
Carosella, ED ;
Dausset, J ;
Kirszenbaum, M .
IMMUNOLOGY TODAY, 1996, 17 (09) :407-409
[8]   HLA-G: a shield against inflammatory aggression [J].
Carosella, ED ;
Moreau, P ;
Aractingi, S ;
Rouas-Freiss, N .
TRENDS IN IMMUNOLOGY, 2001, 22 (10) :553-555
[9]   HLA-G molecules: from maternal-fetal tolerance to tissue acceptance [J].
Carosella, Edgardo D. ;
Moreau, Philippe ;
Le Maoult, Joel ;
Le Discorde, Magali ;
Dausset, Jean ;
Rouas-Freiss, Nathalie .
ADVANCES IN IMMUNOLOGY, VOL 81, 2003, 81 :199-+
[10]   Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival [J].
Castro, MJ ;
Morales, P ;
Rojo-Amigo, R ;
Martinez-Laso, J ;
Allende, L ;
Varela, P ;
Garcia-Berciano, M ;
Guillen-Perales, J ;
Arnaiz-Villena, A .
TISSUE ANTIGENS, 2000, 56 (03) :232-239